Institut de Cancérologie de Montpellier — Montpellier

Public research footprint of Institut de Cancérologie de Montpellier, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Cancer · Prostate Cancer · Breast Cancer · Soft Tissue Sarcoma

Recently updated registry entries

NCT04205799 — Cabozantinib for Advanced or Metastatic Cervical Carcinoma After Platinum Treatment… (Completed)
NCT06876532 — Evaluation of the Inflammation-based Index as a Predictive Marker of Clinical and… (Recruiting)
NCT03784014 — Molecular Profiling of Advanced Soft-tissue Sarcomas (Completed)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Institut de Cancérologie de Montpellier?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.